Why Is Altimmune (ALT) Stock Up 14% Today?

Description

Altimmune stock is rising higher on Monday as ALT investors react to positive news from rival weight loss drugmaker Zealand Pharma.

Altimmune (ALT) to Report Q4 Earnings: What's in the Cards? - February 20, 2024

SNN

Coronavirus Vaccine Hunt Sends Biotech Companies Scrambling To Treat Covid-19

Investing Insights & Market Analysis [Issue #23: Week 50, December 2023]

Altimmune (ALT) - 6 Price Charts 2005-2024 (History)

Eli Lilly Stock: Is LLY Stock A Buy Or A Sell After The FDA Delayed Its Alzheimer's Drug Decision?

Where will Altimmune Stock Be In 1 Year? – Financhill

TEVA Stock Pops 4% as Teva Receives FDA Approval

Wall Street Analysts Think Altimmune, Inc. (ALT) Could Surge 352%: Read This Before Placing a Bet

Altimmune Inc Stock Quote, Stock Price for ALT

Altimmune, Inc: Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide

SNN

$ 4.00USD
Score 4.7(424)
In stock
Continue to book